PerkinElmer Posts 6 Percent Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its fourth-quarter revenues rose 6 percent, while its bottom line was hit by a large asset impairments charge.

The Waltham, Mass.-based analytical tools firm brought in total revenues of $572.9 million for the three months ended Dec. 30, 2012, compared to $539.3 million for the fourth quarter of 2011, and up 3 percent on an organic basis. It beat Wall Street's estimate of $578.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.